Exela Technologies Donates Over $5,500 to the National Breast Cancer Foundation

Exela Technologies Donates Over $5,500 to the National Breast Cancer Foundation

Global fundraising effort highlights Exela’s burgeoning #ExelaGivesBack philanthropy program

NBCF Check

IRVING, Texas, Feb. 11, 2020 -- Exela Technologies, Inc. (“Exela”) (NASDAQ: XELA), a location-agnostic global business process automation (BPA) leader across numerous industries, presented the National Breast Cancer Foundation (NBCF) with a check for $5,540, which Exela raised during Breast Cancer Awareness Month as part of its philanthropy goals. The check presentation ceremony took place at NBCF’s Dallas, Texas headquarters.

Exela’s Senior Vice President of Human Resources, Carlos Mallen, and Katie Beezley, Marketing Event Manager, presented the check to NBCF’s Candice Boeck, Manager of Charitable Gifting and Strategic Partnerships, and Ken Ramirez, SVP of Strategic Partnerships and Charitable Giving. Exela has made donations to the NBCF in previous years and looks forward to furthering its partnership with NBCF in the coming year and beyond.

“We are honored, blessed, and humbled to provide a gift to the foundation, which has worked tirelessly for decades to support the fight against breast cancer by providing financial grants to research institutions and most importantly gifts of hope to patients and their families,” Mallen said.

“NBCF is grateful for the support from Exela Technologies and their employees to our mission of Helping Women Now,” said Candice Boeck, Manager of Charitable Giving & Strategic Partnerships at NBCF. “Their donation will enable us to continue providing help and inspiring hope to women affected by breast cancer across the U.S.”

NBCF, a not-for-profit organization, was founded by breast cancer survivor Janelle Hail in 1991. Its mission is to help women now by providing assistance through early detection, education and support services. According to the NBCF website, 1 in 8 women will be diagnosed with breast cancer in her lifetime. There is currently no known cure for breast cancer, and its early diagnosis is critical to survival. Learn more here: https://www.nationalbreastcancer.org/other/our-impact

About Exela Technologies

Exela is a business process automation (BPA) leader, leveraging a global footprint and proprietary technology to provide digital transformation solutions enhancing quality, productivity, and end-user experience. With decades of experience operating mission-critical processes, Exela serves a growing roster of more than 4,000 customers throughout 50 countries, including over 60% of the Fortune® 100. With foundational technologies spanning information management, workflow automation, and integrated communications, Exela’s software and services include multi-industry department solution suites addressing finance and accounting, human capital management, and legal management, as well as industry-specific solutions for banking, healthcare, insurance, and public sectors. Through cloud-enabled platforms, built on a configurable stack of automation modules, and over 22,000 employees operating in 23 countries, Exela rapidly deploys integrated technology and operations as an end-to-end digital journey partner.

Forward-Looking Statements: Certain statements included in this press release are not historical facts but are forward-looking statements for purposes of the safe harbor provisions under The Private Securities Litigation Reform Act of 1995. Forward-looking statements generally are accompanied by words such as “may”, “should”, “would”, “plan”, “intend”, “anticipate”, “believe”, “estimate”, “predict”, “potential”, “seem”, “seek”, “continue”, “future”, “will”, “expect”, “outlook” or other similar words, phrases or expressions. These forward-looking statements include statements regarding our industry, future events, the estimated or anticipated future results and benefits of the Business Combination, future opportunities for the combined company, and other statements that are not historical facts. These statements are based on the current expectations of Exela management and are not predictions of actual performance. These statements are subject to a number of risks and uncertainties, including without limitation those discussed under the heading “Risk Factors” in Exela’s most recently filed Annual Report on Form-10-K filed with the Securities and Exchange Commission. In addition, forward-looking statements provide Exela’s expectations, plans or forecasts of future events and views as of the date of this communication. Exela anticipates that subsequent events and developments will cause Exela’s assessments to change. These forward-looking statements should not be relied upon as representing Exela’s assessments as of any date subsequent to the date of this press release.

Find out more at www.exelatech.com.

Follow Exela on LinkedIn: https://www.linkedin.com/company/exela-technologies/

Follow Exela on Twitter: https://twitter.com/exelatech

Media Contact: Kevin McLaughlin
Ekevin.mclaughlin@icrinc.com
T: 646-277-1234

Investor Contact: William Maina
EIR@exelatech.com
T: 646-277-1236